• At Last

    by Sharan Abdul-Rahman, MD
    on Aug 20th, 2015

This week Flibanserin (Addyi) was approved by the FDA, making it the first medication prescribed for decreased female libido otherwise known as female hypoactive sexual desire disorder (HSDD). 

Decreased libido has been less of an issue for men. Male sexual dysfunction has focused on erectile dysfunction. Multiple medications have been FDA approved for erectile dysfunction. Viagra, the first of such medications, was approved by the FDA in 1998.

The results with Flibanserin are not impressive. It was only tested on premenopausal women. It requires daily use. There are side effects. But it is a start. 

FDA approval of Flibanserin (Addyi) is a small step in the right direction. Female sexuality is complex. We need to continue the conversation and the research on female sexuality. 

Author Sharan Abdul-Rahman, MD

You Might Also Enjoy...

Why MonaLisa

Fractional CO2 laser treatment for symptomatic menopausal women.

Spring has sprung.

At some point you realize that it’s not about longevity but about the quality of your life. Live well.

MonaLisa Touch - FAQs

Frequently asked questions about the novel treatment for vulvar/vaginal changes due to menopause including vaginal dryness, buring, and pain with sex.

Location
Today's Woman
1015 Chestnut Street, Suite 907
Philadelphia, PA 19107
Phone: 267-388-2976
Office Hours

Get in touch

267-388-2976